Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01145898 · ClinicalTrials.gov registry record
Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data
A clinical trial of Glaucoma, sponsored by Indiana University.
- Completed
- Registry status
- 56
- Enrollment target
- 1
- Study location
NCT01145898: Completed study of Glaucoma, sponsored by Indiana University.
NCT01145898 is a study of Glaucoma that has completed, run by Indiana University. The registered enrollment target is 56 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01145898, a study of Glaucoma, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
To analyze Cosopt® in terms of its effects on ocular perfusion pressure and comprehensive ocular blood flow and in relation to visual field progression and optic nerve structural changes in an ongoing 3 year prospective study involving 120 patients with open angle glaucoma.
Primary Outcome
Measurement of change in ocular blood flow - ophthalmic artery peak systolic velocity
Conditions Studied
Interventions
- DRUG (Cosopt®, prostaglandin)
Study Locations (1)
Indiana
- Indiana University School of Medicine, Department of Ophthalmology - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-10 |
What the finished NCT01145898 record still lists
NCT01145898 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which (Cosopt®, prostaglandin) is the first listed.
NCT01145898 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT01145898 about?
NCT01145898 is a clinical study titled "Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data". To analyze Cosopt® in terms of its effects on ocular perfusion pressure and comprehensive ocular blood flow and in relation to visual field progression and optic nerve structural changes in an ongoing 3 year prospective study involving 120 patients with open angle glaucoma.
What is the current status of trial NCT01145898?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2010-06. Estimated completion is 2012-10.
What conditions does trial NCT01145898 study?
This clinical trial studies the following conditions: Glaucoma.
What interventions are being tested in trial NCT01145898?
The interventions under investigation include: (Cosopt®, prostaglandin) (DRUG).
Who is sponsoring clinical trial NCT01145898?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01145898 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01145898's enrollment target sits among peer trials
56 63rd of 92 higher than 30 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia